Skip to main content
Livermore
Livermore
ZHEN

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

PCRX holding history

Pacira BioSciences, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings

Shares (Q2 2026)
129,348
Value
$3.28M
% of portfolio
<0.1%
Quarters held
16
Since Q1 2021
Holdings of PCRX by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026129,348$3.28M<0.1%+129,348NewHolders
Q3 20250$00.0%−190,366−100.0%Sold outHolders
Q2 2025190,366$4.55M<0.1%+190,366NewHolders
Q1 20250$00.0%−42,613−100.0%Sold outHolders
Q4 202442,613$802.8K<0.1%−482,336−91.9%ReducedHolders
Q3 2024524,949$7.90M<0.1%−446,194−45.9%ReducedHolders
Q2 2024971,143$27.8M<0.1%+159,791+19.7%AddedHolders
Q1 2024811,352$23.7M<0.1%+331,159+69.0%AddedHolders
Q4 2023480,193$16.2M<0.1%−5,452−1.1%ReducedHolders
Q3 2023485,645$14.9M<0.1%+97,348+25.1%AddedHolders
Q2 2023388,297$15.6M<0.1%+69,136+21.7%AddedHolders
Q1 2023319,161$13.0M<0.1%+193,804+154.6%AddedHolders
Q4 2022125,357$4.84M<0.1%+82,396+191.8%AddedHolders
Q3 202242,961$2.29M<0.1%+24,638+134.5%AddedHolders
Q2 202218,323$1.07M<0.1%+18,323NewHolders
Q1 20220$00.0%−205,322−100.0%Sold outHolders
Q4 2021205,322$12.4M<0.1%+190,381+1,274.2%AddedHolders
Q3 202114,941$837.0K<0.1%+14,941NewHolders
Q2 20210$00.0%−30,624−100.0%Sold outHolders
Q1 202130,624$2.15M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.